drugset / Trial / NCT01188759
Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to compare the safety, tolerability, and efficacy of voriconazole and anidulafungin in combination versus voriconazole alone in pediatric subjects aged 2 to 17 years with invasive aspergillosis.
Timeline
- Start
- 2012-05
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anidulafungin | Other / unclassified | 1.5 mg/kg | Intravenous |
| Comparator | Voriconazole | Small molecule | 4 mg/kg | Intravenous |
| Comparator | Voriconazole | Small molecule | 8 mg/kg | Intravenous |
| Comparator | Voriconazole | Small molecule | 9 mg/kg | Intravenous |
| Comparator | Voriconazole | Small molecule | 200 mg | Intravenous |